3.2(top 10%)
impact factor
426(top 50%)
papers
16.9K(top 10%)
citations
70(top 10%)
h-index
3.6(top 10%)
impact factor
979
all documents
17.5K
doc citations
121(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Mechanisms of Disease: is osteoporosis the obesity of bone?Nature Clinical Practice Rheumatology2006810
2Interleukin 6: from bench to bedsideNature Clinical Practice Rheumatology2006536
3Control of autoimmune diseases by the vitamin D endocrine systemNature Clinical Practice Rheumatology2008477
4Adipokines as emerging mediators of immune response and inflammationNature Clinical Practice Rheumatology2007457
5Genomic and nongenomic effects of glucocorticoidsNature Clinical Practice Rheumatology2008456
6Tendinopathy—from basic science to treatmentNature Clinical Practice Rheumatology2008381
7Mechanisms of Disease: atherosclerosis in autoimmune diseasesNature Clinical Practice Rheumatology2006309
8Mechanisms of Disease: a 'DAMP' view of inflammatory arthritisNature Clinical Practice Rheumatology2007307
9Nature and functions of autoantibodiesNature Clinical Practice Rheumatology2008289
10Mechanisms of Disease: the molecular and cellular basis of joint destruction in rheumatoid arthritisNature Clinical Practice Rheumatology2005272
11Technology Insight: adult stem cells in cartilage regeneration and tissue engineeringNature Clinical Practice Rheumatology2006270
12Primer: inflammasomes and interleukin 1β in inflammatory disordersNature Clinical Practice Rheumatology2008268
13Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?Nature Clinical Practice Rheumatology2008257
14Behçet's syndrome: disease manifestations, management, and advances in treatmentNature Clinical Practice Rheumatology2007247
15Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factorNature Clinical Practice Rheumatology2006242
16Technology Insight: adult mesenchymal stem cells for osteoarthritis therapyNature Clinical Practice Rheumatology2008242
17Mechanisms of Disease: role of chondrocytes in the pathogenesis of osteoarthritis—structure, chaos and senescenceNature Clinical Practice Rheumatology2007220
18Biological markers in osteoarthritisNature Clinical Practice Rheumatology2007196
19Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitidesNature Clinical Practice Rheumatology2006191
20Mechanisms of Disease: pain in fibromyalgia syndromeNature Clinical Practice Rheumatology2006183
21Pain measurement in patients with low back painNature Clinical Practice Rheumatology2007178
22Mechanisms of Disease: angiogenesis in inflammatory diseasesNature Clinical Practice Rheumatology2007178
23Mechanisms of Disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritisNature Clinical Practice Rheumatology2006170
24Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritisNature Clinical Practice Rheumatology2008170
25Granulocyte colony-stimulating factor and neutrophils—forgotten mediators of inflammatory diseaseNature Clinical Practice Rheumatology2006161
26Primer: administrative health databases in observational studies of drug effects—advantages and disadvantagesNature Clinical Practice Rheumatology2007159
27Mechanisms and consequences of fibrosis in systemic sclerosisNature Clinical Practice Rheumatology2006158
28Mechanisms of Disease: the link between RANKL and arthritic bone diseaseNature Clinical Practice Rheumatology2005157
29The changing epidemiology of goutNature Clinical Practice Rheumatology2007155
30Prospects for disease modification in osteoarthritisNature Clinical Practice Rheumatology2006143
31Wnt–β-catenin signaling in the pathogenesis of osteoarthritisNature Clinical Practice Rheumatology2008141
32Potential new drug targets for osteoporosisNature Clinical Practice Rheumatology2009141
33Primer: epigenetics of autoimmunityNature Clinical Practice Rheumatology2007137
34Cryopyrinopathies: update on pathogenesis and treatmentNature Clinical Practice Rheumatology2008135
35CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseasesNature Clinical Practice Rheumatology2007133
36Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosisNature Clinical Practice Rheumatology2006130
37The effect of melanism and vitamin D synthesis on the incidence of autoimmune diseaseNature Clinical Practice Rheumatology2009129
38A case of macrophage activation syndrome successfully treated with anakinraNature Clinical Practice Rheumatology2008128
39Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesisNature Clinical Practice Rheumatology2007126
40Risk factors and prognostic factors of hip and knee osteoarthritisNature Clinical Practice Rheumatology2007125
41Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosusNature Clinical Practice Rheumatology2006124
42Tobacco smoking and autoimmune rheumatic diseasesNature Clinical Practice Rheumatology2007124
43Chronic recurrent multifocal osteomyelitis: what is it and how should it be treated?Nature Clinical Practice Rheumatology2007120
44MicroRNAs, the immune system and rheumatic diseaseNature Clinical Practice Rheumatology2008117
45Systemic juvenile idiopathic arthritis: diagnosis, management, and outcomeNature Clinical Practice Rheumatology2006115
46Mode of action of hydroxychloroquine in RA—evidence of an inhibitory effect on toll-like receptor signalingNature Clinical Practice Rheumatology2006114
47New insights into the pathogenesis and genetics of psoriatic arthritisNature Clinical Practice Rheumatology2009112
48The management of Sjögren's syndromeNature Clinical Practice Rheumatology2006110
49Cognitive behavioral therapy for fibromyalgiaNature Clinical Practice Rheumatology2006110
50Angiogenesis inhibition as a therapeutic approach for inflammatory synovitisNature Clinical Practice Rheumatology2007107